July 28th 2019 marked World Hepatitis Day.
Each year on this day, we have an opportunity to reflect how far we have come on the path to eliminating hepatitis globally, but also, to think how much more needs to be done to achieve this goal by 2030. ‘Invest in eliminating hepatitis’, this year’s theme could not be more timely in encouraging us all to set a clear direction for investment to ensure long-term, patient-focused results can be reached.
It saddens me to see the large number of people still living in the EU/EEA with Hepatitis B – which is preventable, and Hepatitis C – which is both preventable and curable. The figures are overwhelming – an estimated 4.7 million people are chronically infected with hepatitis B, 3.9 million with hepatitis C, and we lose more lives to Hepatitis B and C than HIV/AIDS and tuberculosis combined. How in 2019 can this be? How can it be that unimaginable suffering and stigma is endured by so many in Europe, and precious lives lost?
To read this statement in full go to: http://europa.eu/rapid/press-release_STATEMENT-19-4771_en.htm